WELL Health Technologies Corp

05/20/2026

WELL was recently featured in an interview on Cantech Letter, where Founder and CEO Hamed Shahbazi discussed the Company's record Q1 2026 financial results and its growing impact on healthcare delivery across Canada.

Watch the full interview here:

After yet another record quarter, WELL Health Technologies CEO Hame...

05/19/2026

Today, on World Family Doctor Day, we extend our gratitude to the family physicians who form the foundation of our healthcare system.

Family doctors are often the first point of care, the steady voice through life’s challenges, and trusted partners in long-term health and wellbeing. Their compassion, dedication, and expertise make an immeasurable impact across every stage of life.

To all family physicians across the WELL Health network and beyond - thank you for the care, trust, and commitment you bring to every patient interaction.

05/19/2026

WELL is pleased to announce that the Notice of Intention to Make a Normal Course Issuer Bid it filed with the Toronto Stock Exchange has been approved by the TSX and has subsequently entered into an automatic share purchase plan with a broker to facilitate repurchases of the Company's common shares.

Read full press release here: https://ow.ly/9YS750Z1HvS

05/07/2026

WELL is pleased to announce its interim consolidated financial results for the quarter ended March 31, 2026.

📌 WELL achieved quarterly revenues of $368.3 million in Q1-2026, an increase of 25% as compared to Q1-2025 driven by organic growth, acquisitions and the inclusion of HEALWELL results in WELL’s consolidated financial reporting.

📌 WELL achieved Adjusted EBITDA of $43.1 million in Q1-2026, an increase of 56% as compared to Q1-2025, representing an Adjusted EBITDA Margin of 12%.

📌 Canadian Patient Services revenues increased by 30% to $130.3 million and Adjusted EBITDA increased by 28% to $17.0 million in Q1-2026, driven by acquisitions and organic growth of 8% for the Canadian Patient Services business.

📌 WELL recorded a total of 1.9 million patient visits in Q1-2026, an increase of 17% as compared to Q1-2025, driven by 33% YoY growth of Canadian patient services visits and strong organic growth of 13% in Canada.

📌 WELL reaffirms its previously provided guidance for annual revenue between $1.55 billion to $1.65 billion with Adjusted EBITDA in the range of $175 million to $185 million.

WELL CEO Hamed Shahbazi commented “We are very pleased to report a strong start to 2026, with solid first quarter performance that saw our revenue run rate approach the $1.5 billion per year mark."

View full press release here: https://ow.ly/6zKn50YWiYc

05/01/2026

To the physicians of the WELL Health Clinic Network, thank you for the vital role you play in delivering high-quality care to patients and communities across the country.

Your dedication extends far beyond the exam room. It’s reflected in the trust you build, the outcomes you improve, and the compassion you bring to every patient interaction.

We are grateful for the opportunity to support your work and to collaborate with such a committed and talented group of professionals.

Thank you for everything you do - today and every day.

04/28/2026

WELL is pleased to announce that the Company will release its Fiscal First Quarter 2026 financial results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026.

WELL will hold a conference call and simultaneous webcast to discuss its results on the same day, at 5:00 pm ET (2:00 pm PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer, and Eva Fong, Chief Financial Officer.

Click here to register for the webcast: well.company/events

04/27/2026

Watch Hamed Shahbazi, Founder and CEO of WELL Health, in an exclusive interview with Cantech Letter, where he shared insights on WELL’s record 2025 financial performance and the company’s strategic priorities for 2026.

Shahbazi discussed how WELL has grown from approximately $50 million in annual revenue five years ago to more than $1.4 billion in 2025, representing 52% year-over-year growth.

Plus, he highlighted strong free cash flow growth, continued momentum across WELL’s Canadian clinic platform, and the company’s expanding role in modernizing healthcare delivery through technology and AI.

Watch full interview here:

3 likes. "WELL Health (TSX:WELL) CEO interview, April 2026"

04/21/2026

WELL today reported record quarterly patient visits across its Canadian Clinics network and highlighted continued organic growth, margin expansion in its Primary Care segment, the continued scaling of its Affiliate Clinic network, and strong momentum in its CardiologyNow virtual specialty-care platform.

📌WELL Canada delivered a record ~1.27 million patient visits in Q1-2026, representing 33% year-over-year growth and 13% organic growth.

📌Affiliate Clinic network expanded to 74 licensee locations, reflecting the continued build-out of WELL’s ten-year strategic alliance with a large retailer that WELL partnered with in December 2024.

📌CardiologyNow virtual visits grew 65% year-to-date, supported by expanded specialist capacity and strong referral demand, reinforcing its role as a key access point into WELL’s national diagnostics network.

Read more here: https://ow.ly/4UGH50YNt9O

04/14/2026

WELL is pleased to announce that its majority-owned subsidiary, CYBERWELL, has provided a strategic business update highlighting its unified operating model, proprietary platform capabilities, key certifications, and leadership appointments.

📌Consolidated operating model powered by new unified platform, CYDEcore™ Fusion: WELL’s prior cybersecurity assets of Cycura, Seekintoo, and Proack are now integrated into a single cybersecurity organization with centralized leadership, governance, and service delivery.

📌Key certifications and platform milestones: CYBERWELL has completed its SOC2 Type I certification completed, Microsoft Security Solutions Partner designation earned, and enterprise clients live on CYBERWELL’s XSOAR-based managed security platform.

📌Experienced leadership and Advisory Board: CYBERWELL welcomes new experienced executives to its leadership team and cybersecurity advisors with expertise in national security, public policy, and regulated industries to its newly formed Advisory Board.

Read full details here: https://ow.ly/wnJp50YIVEL

04/13/2026

WELL and its majority-owned subsidiary WELLSTAR, are pleased to announce their participation as presenting companies at the 2026 Bloom Burton & Co. Healthcare Investor Conference on April 21-22, 2026 in Toronto, Ontario at the Metro Toronto Convention Centre.

Representatives from WELL and WELLSTAR will deliver corporate presentations and participate in one-on-one meetings with investors during the conference.

Full details: https://ow.ly/6MWe50YIepk

04/02/2026

WELL is pleased to announce a strategic partnership with AliveCor, Inc. (“AliveCor”), the global leader in AI-powered personal electrocardiogram (ECG) technology.

The collaboration integrates WELL Health’s expanding national network of Canadian-licensed cardiologists with AliveCor’s Kardia solution and services, enabling patients to receive timely, expert clinical interpretation of their heart data from home.

Learn more: https://ow.ly/shel50YCgLn